Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Ågren

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Thrombosis Research|March 29, 2017
Whole blood coagulation assays ROTEM and T-TAS to monitor dabigatran treatmentViktor Taune, Håkan Wallén, Anna Ågren, et al.
Blood|August 25, 2017
Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort studyAmmar Majeed, Anna Ågren, Margareta Holmström, et al.
Thrombosis Research|March 18, 2014
Studies of fibrin formation and fibrinolytic function in patients with the antiphospholipid syndromeAnna Vikerfors, Elisabet Svenungsson, Anna Ågren, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|March 10, 2022
Hypercoagulation Detected by Rotational Thromboelastometry Predicts Mortality in COVID-19: A Risk Model Based on a Prospective Observational StudyLou M Almskog, Agneta Wikman, Jonas Svensson, et al.
Thrombosis Research|July 4, 2017
Thrombin activatable fibrinolysis inhibitor (TAFI) - A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS)Giorgia Grosso, Anna Vikerfors, Barry Woodhams, et al.
International Urology and Nephrology|April 3, 2022
Platelet thrombus formation in patients with end-stage renal disease before and after hemodialysis as measured by the total thrombus-formation analysis systemBranka P Mitic, Zorica M Dimitrijevic, Kazuya Hosokawa, et al.
Thrombosis Research|September 3, 2024
Tocilizumab reduces hypercoagulation in COVID-19 - Perspectives from the coagulation and immunomodulation Covid assessment (Coag-ImmCovA) clinical trialLou M Almskog, Anna Sjöström, Jonas Sundén-Cullberg, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Thrombosis Research|March 29, 2017
Whole blood coagulation assays ROTEM and T-TAS to monitor dabigatran treatmentViktor Taune, Håkan Wallén, Anna Ågren, et al.
Blood|August 25, 2017
Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort studyAmmar Majeed, Anna Ågren, Margareta Holmström, et al.
Thrombosis Research|March 18, 2014
Studies of fibrin formation and fibrinolytic function in patients with the antiphospholipid syndromeAnna Vikerfors, Elisabet Svenungsson, Anna Ågren, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|March 10, 2022
Hypercoagulation Detected by Rotational Thromboelastometry Predicts Mortality in COVID-19: A Risk Model Based on a Prospective Observational StudyLou M Almskog, Agneta Wikman, Jonas Svensson, et al.
Thrombosis Research|July 4, 2017
Thrombin activatable fibrinolysis inhibitor (TAFI) - A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS)Giorgia Grosso, Anna Vikerfors, Barry Woodhams, et al.
International Urology and Nephrology|April 3, 2022
Platelet thrombus formation in patients with end-stage renal disease before and after hemodialysis as measured by the total thrombus-formation analysis systemBranka P Mitic, Zorica M Dimitrijevic, Kazuya Hosokawa, et al.
Thrombosis Research|September 3, 2024
Tocilizumab reduces hypercoagulation in COVID-19 - Perspectives from the coagulation and immunomodulation Covid assessment (Coag-ImmCovA) clinical trialLou M Almskog, Anna Sjöström, Jonas Sundén-Cullberg, et al.
Pageof 4